that statement is ignorant because the company has 240 million shares outstanding and the truth is that the average joe here manages 5k to 1 million dollars and assuming average intelligence has not more than a 20% postition in the stock, so even if someone could get everyone on the same day to buy or sell, it still wouldn't move this stock.
I have to admit I have followed and you have been very astute and accurate.
One question why are you coming out in full force with so many posts?
Where did you disappear to?
Do you really think a large bio would buy out a company with no drug and just technology that could probably be copied?
I don't think a biotech would buy a technology????
That same ignorant thinking would have lost a lot of people Money by saying its at .50 cents a couple weeks ago, now .60, now .80, now .90, it will head to 1.20.
I personally hope for your own safety your not invested in the market
There is the possibility of trial data toward the end of the year as the trials are open label, but easily could be Q1 of next year. Remember the trials they are running are orphand status and there are no drugs available, so any type of good numbers will be huge for this stock. There are only 13 million shares outstanding and a very low float. This stock can jump $7 in a day.
I think they hinted at break-even to a small profit when you back out 400k for one time costs and guidance for higher margins
2 things we can conclude today
1. Your not very good at managing money.
2. You don't run a business for a living
I personally hope you don't manager your family's retirement money and this is just a small trading account.
i don't think anyone understood your post, please post again and use english! Thanks
Your really smart, so how does the company raise cash for clinical trials?
If you were ceo, what would you do at this point, so lets scrap all the current trials and technology. You have $21 million what do you do? Buy another biotech? Buy patents to drugs? Your pretty savvy with investments and biotechnology back ground, please share?
Also could you post your education level?
this stock starts to move closer to $20 as there is only 13 million shares outstanding and we will be very close to trial data and remember these drugs if positive data have strong posibility for Accelerated Approval meaning they will skip phase 3 and ask FDA for immediate approval. If the numbers are strong enough to support, this stock jumps back to $30. 200,000 shares trading volume can send this stock up $10. Managment is really strong if you read the bios.
it is a concern but it is expected. Small unproven biotechs like the many others have to issue shares to raise more money to do trials to prove there is potential. ONCS should be good till late next year so trials can report data, which raises the price and maybe they partner or they will dilute again.
Anyone that doesn't know this has their head in the sand. I think once this stock has their ducks in a row, they will announce a reverse split 10-1 so they will have 25 million shares outstanding. This would take the stock to $4.00 at current price.
University of South Florida License
On August 24, 2012, we secured an exclusive license for specific patented technology from the University of South Florida Research Foundation relating to the delivery of gene-based therapeutics via intratumoral and intramuscular electroporation. This patent directly supports our clinical development focus in solid tumor applications and specifically in metastatic melanoma, Merkel cell carcinoma and cutaneous T-cell lymphoma using our ImmunoPulse therapy, and extends patent protection for the ImmunoPulse technology through the year 2024.
Old Dominion University Sponsored Research Agreement
On June 4, 2013, we entered into a sponsored research agreement with Old Dominion University and The Frank Reidy Research Center for Bioelectrics (the “ODU SRA”). The intent of the ODU SRA was to pursue some or all of the following goals in furtherance of our operational milestones: (i) to initiate and collaborate on nonclinical research focused on developing new technology related to electroporation and delivery of different agents into solid tumors by electroporation, (ii) to pursue exploratory research to support the development of ImmunoPulse for our melanoma program and other solid tumor malignancies in response to new advances being made in the melanoma field and (iii) to support additional research and development on our electroporation parameters for certain targets. Our initial work order under the ODU SRA was submitted concurrently with our execution of the ODU SRA and we have submitted subsequent work orders for additional research under the ODU SRA since its execution, including during the nine month period ended April 30, 2014.
i'm open minded. What your forgetting is there are people smarter than you and I both that have PHD's that are investing in this company. In all honesty, no one here cares if they come up with a drug.....If the stock price rises based upon the HOPE of a new drug, that all anyone cares about. It is about making money. If this stock is a scam and they pump the stock up to 15 to 20, no one cares as long as they made money and sold.
Your missing the point! My guess is you don't invest in the stock market?
your post just showed you have never been in the corporate world and further more your lack of experience in investing.
with all due respect...people don't just waste their personal money. 2 million dollars is a strong vote of confidence. Apple's has been a #$%$ stock for over 20 years untill they came out with Ipod and prior to that they had garbage technology and computers. they had many flops that they brought to the market.
Your repetitive rants are filled with ignorance. click on your name and honestly read your posts. You sound like a bitter person with a vendeta against Ino and oncs. Remember, most of us have been long-term investors, we have portfolios with other stocks and if this does go to zero, its just a tax write off and everyone moves on. Go enjoy your day! call a friend and say hello....maybe research a company you can make money on. (Life is to short my friend)